Scott Dooley

Scott Dooley is a Senior Scientist at Sanofi, where they focus on developing innovative therapies for both rare and common diseases. With undergraduate and Master’s degrees in Biochemistry and a Master's in Business Administration, Scott's research has concentrated on rare diseases. They have extensive experience in analytical development, including determining product quality attributes and overseeing stability studies for enzyme replacement therapies and gene therapy platforms. Previously, Scott held various research and teaching roles at the University of Massachusetts Amherst and Genzyme, enhancing their expertise in protein interactions and immunology.